6098-80-2 Usage
Xanthene class
Organic compound The compound belongs to the xanthene class, which is a group of organic compounds that have a common structure consisting of two fused benzene rings and a central oxygen atom.
Fluorescent dye
Bright red color The compound is used as a fluorescent dye due to its bright red color, which makes it suitable for various applications.
pH indicator
Color change with pH As a pH indicator, the compound changes color depending on the acidity or alkalinity of a solution, making it useful for monitoring pH levels.
Textile industry
Dyeing fabrics The compound is used in the textile industry to dye fabrics, providing a vibrant red color to the materials.
Cosmetics and food products
Adding color The compound is also used in cosmetics and food products to add a red color to these items.
Biological research
Fluorescent label In biological research, the compound serves as a fluorescent label, allowing scientists to visualize and study cellular processes and structures.
Pharmaceutical properties
Antioxidant and anti-inflammatory activities The compound has potential pharmaceutical properties, including antioxidant and anti-inflammatory activities, which have been studied for their potential use in treating cancer and other diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 6098-80-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,0,9 and 8 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 6098-80:
(6*6)+(5*0)+(4*9)+(3*8)+(2*8)+(1*0)=112
112 % 10 = 2
So 6098-80-2 is a valid CAS Registry Number.
6098-80-2Relevant articles and documents
9-(4'-dimethylaminophenyl)-2,6,7-trihydroxy-xanthene-3-one is a potentially novel antiplatelet drug which antagonizes the effect of thromboxane A2
Applová, Lenka,Mlad?nka, P?emysl,Veljovi?, Elma,Muratovi?, Samija,Zavr?nik, Davorka,Karlí?ková, Jana,Macáková, Kate?ina,Saso, Luciano,Duri?, Kemal
, p. 200 - 209 (2018/03/22)
Background: Currently, used oral antiplatelet drugs are both limited and associated with the risk of treatment failure/resistance. Research in this area is hence highly desired. A series of xanthene-3-ones derivatives, we had synthesized, showed us that t
